RAD140 Phase 1 HUMAN TRIAL Using 150 MG PER DAY Results

More Plates More Dates

Health & Fitness, Science, Education, Self-improvement

4.9 • 806 Ratings

🗓️ 18 May 2020

⏱️ 10 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

One Phase 1 study on the SARM RAD140 has been conducted [R]. The Phase 1 trials are the first stage of testing in human subjects designed to assess safety, side effects, best dosage, and formulation method for the drug. In this podcast episode, I go over the recently published results of that trial. https://moreplatesmoredates.com/rad140-testolone-review/#rad140_clinical_trials

Transcript

Click on a timestamp to play from that location

0:00.0	So up guys, Derek, more plates, more dates.com.
0:02.0	Today we're going to be talking about an update to the RAD 140 human trials.
0:08.0	So, you know, there's not, some of the hype has died down in the SARMs world around the clinical testing.
0:15.5	Some, you know, there's like the failed Austrian study.
0:18.4	LGD got, didn't get shelved, but it has sort of encountered, I guess, obstacles in terms of
0:25.6	getting, you know, phase three trials done in the States for the target, you know, therapeutic
0:33.3	intervention they were originally designing it for, which was hip fractures.
0:38.0	And then now, RAD 140 in particular, so this is something I've covered before, but it's
0:44.2	obviously worth updating because a lot of people following my channel obviously followed my
0:48.9	SARMs content.
0:50.4	And frankly, if you haven't seen any of my SARMs overviews, I without a doubt have the most comprehensive overviews of every single SARM on the entire internet.
0:59.6	Like there's nobody who has broken them down in the elaborate detail I have.
1:02.7	So I highly recommend if you haven't checked out my articles, which have all the citations in there, or the videos themselves, which are essentially just a video representation of what my written article is.
1:15.0	I highly recommend you check those out. But as far as RAD 140, so I had outlined before in my overview that in a preclinical study, RAD 140 significantly suppressed the growth and proliferation of breast cancer cells in vivo and in vitro
1:30.2	models of AR and ER, AR-R-endrogen receptor, and estrogen receptor-positive breast cancer.
1:36.2	RAD-140 has a promising preclinical profile and radius health.
1:39.9	They're the company who's developing it right now.
1:41.9	It's currently in the process of recruiting 40 postmenopausal
1:45.2	women with hormone receptor positive breast cancer into its first phase one clinical trial on
1:49.9	humans the main goal the study is to evaluate its safety profile tolerability pharmacokinetic
1:54.7	characteristics in hormone receptor positive breast cancer so you know one of the main criticisms of SARMs is that
2:03.6	the dosages using the studies are way lower than what people are using for performance
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from More Plates More Dates, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of More Plates More Dates and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.